MNPR logo

Monopar Therapeutics (MNPR)

Profile

Full Name

Monopar Therapeutics Inc.

Ticker Symbol

MNPR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 19, 2019

Indexes

Not included

Website

http://www.monopartx.com

Employees

9

Key Details

Price

$34.89(+9.48%)

Market cap

$213.27M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$4.11(-35.20% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$34.89
MNPR price is $34.89

30-Day Relative Volume

0.49
MNPR 30-day relative volume is 0.49

Price Performance

Price Most recent change

+9.48%
MNPR price was up +9.48% on Apr 11, 2025

Price YTD change

+58.59%
MNPR price is up +58.59% since January 1st

Price 1-year change

+806.23%
MNPR price is up +806.23% year-on-year

Price 3-year change

+181.37%
MNPR price is up +181.37% over the past 3 years

Price Range

Price All-time high

$135.00
MNPR price is currently -74.16% below its historical high of $135.00

Price 3-year low

$0.27
MNPR price is currently >+9900.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$213.27M
MNPR market capitalization is $213.27 million

Market cap 3-year change

+581.39%
MNPR market capitalization is up +581.39% over the past 3 years

Market cap All-time high

$316.66M
MNPR market capitalization is currently -32.65% below its historical high of $316.66 million

Market cap sector rank

58.75%
MNPR market capitalization is higher than 58.75% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+74.81%
MNPR shares outstanding is up +74.81% year-on-year

Shares Outstanding 3-Year Change

+142.17%
MNPR shares outstanding is up +142.17% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

2.00
MNPR beta is 2.00

200-day SMA

$18.77
MNPR price is currently +85.85% above its 200-day simple moving average

50-day SMA

$37.45
MNPR price is currently -6.84% below its 50-day simple moving average

RSI

50.48
MNPR 14-day relative strength index is 50.48

Volume

0.49
MNPR 30-day relative volume is 0.49

ATR

$5.21
MNPR average true range is $5.21

10-day Historical Volatility

162.05%
MNPR 10-day historical volatility is 162.05%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
MNPR annual revenue value is unknown

Revenue Analysts estimate

-
MNPR annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
MNPR annual revenue 1-year change is unknown

Revenue Sector rank

-
MNPR annual revenue is unknown

EPS

EPS

-$4.11
MNPR annual earnings per share is -$4.11

EPS Analysts estimate

-$2.63
MNPR annual earnings per share is currently +56.08% higher than the consensus analysts' forecast

EPS 1-year change

-35.2%
MNPR annual earnings per share is down -35.2% year-on-year

EPS Sector rank

22.3%
MNPR annual earnings per share is higher than 22.3% of companies in Healthcare sector

Profit

Gross profit

-
MNPR annual gross profit value is unknown

Gross margin

-
MNPR annual gross profit margin value is unknown

Operating profit

-$16.16M
MNPR annual operating income is -$16.16 million

Operating margin

-
MNPR annual operating profit margin value is unknown

Net income

-$15.59M
MNPR annual net profit is -$15.59 million

Net margin

-
MNPR annual net profit margin value is unknown

Expenses

Total expenses

$16.16M
MNPR annual total expenses is $16.16 million

Operating expenses

$16.16M
MNPR annual total operating expenses is $16.16 million

Cost of goods sold

-
MNPR annual cost of goods sold value is unknown

Selling, general & administrative expenses

$3.16M
MNPR annual SGA is $3.16 million

Depreciation and amortization

-
MNPR annual depreciation & amortization value is unknown

Interest expense

-
MNPR annual interest expense value is unknown

Income tax

-
MNPR annual income tax value is unknown

EBIT & EBITDA

EBIT

-$16.16M
MNPR annual earnings before interest & taxes is -$16.16 million

EBITDA

-$16.16M
MNPR annual EBITDA is -$16.16 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$60.29M
MNPR annual total assets is $60.29 million

Non current assets

$0.00
MNPR annual long term assets is $0.00

Current assets

$60.29M
MNPR annual total current assets is $60.29 million

Cash and cash equivalents

$45.82M
MNPR annual cash & cash equivalents is $45.82 million

Accounts receivable

-
MNPR annual accounts receivable value is unknown

Inventory

-
MNPR annual inventory value is unknown

Liabilities

Total liabilities

$5.25M
MNPR annual total liabilities is $5.25 million

Long term liabilities

$0.00
MNPR annual total long term liabilities is $0.00

Current liabilities

$5.25M
MNPR annual total current liabilities is $5.25 million

Accounts payable

$2.25M
MNPR annual accounts payable is $2.25 million

Debt

Total debt

$0.00
MNPR annual total debt is $0.00

Total debt 1-year change

0%
MNPR {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
MNPR annual long term debt value is unknown

Short term debt

-
MNPR annual short term debt value is unknown

Equity & Capital

Shareholders equity

$55.04M
MNPR annual stockholders equity is $55.04 million

Book value

$55.04M
MNPR annual book value is $55.04 million

Retained earnings

-$75.79M
MNPR annual retained earnings is -$75.79 million

Working capital

$55.04M
MNPR annual working capital is $55.04 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$6.40M
MNPR annual cash flow from operations is -$6.40 million

Cash from operations 1-year change

+18.51%
MNPR annual cash flow from operations is up +18.51% year-on-year

Cash from investing

-$14.34M
MNPR annual cash flow from investing activities is -$14.34 million

Cash from investing 1-year change

-390.98%
MNPR annual cash flow from investing activities is down -390.98% year-on-year

Cash from financing

$59.29M
MNPR annual cash flow from financing activities is $59.29 million

Cash from financing 1-year change

+2824.84%
MNPR annual cash flow from financing activities is up +2824.84% year-on-year

CAPEX

CAPEX

-
MNPR annual capital expenditures value is unknown

CAPEX 1-year change

-
MNPR annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$6.40M
MNPR annual free cash flow is -$6.40 million

Free cash flow 1-year change

+18.51%
MNPR annual free cash flow is up +18.51% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
MNPR annual gross profit margin value is unknown

Operating margin

-
MNPR annual operating profit margin value is unknown

Net margin

-
MNPR annual net profit margin value is unknown

ROA & ROE

ROA

-25.85%
MNPR annual return on assets is -25.85%

ROE

-28.32%
MNPR annual return on equity is -28.32%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
MNPR price to earnings ratio value is unknown

PE ratio Sector rank

-
MNPR price to earnings ratio is unknown

PB Ratio

PB ratio

3.88
MNPR price to book ratio is 3.88

PB ratio Sector rank

78.78%
MNPR price to book ratio is higher than 78.78% of companies in Healthcare sector

PS Ratio

PS ratio

-
MNPR price to sales ratio value is unknown

PS ratio Sector rank

-
MNPR price to sales ratio is unknown

Enterprise value

Enterprise value

$167.45M
MNPR enterprise value is $167.45 million

Enterprise value Sector rank

56.55%
MNPR enterprise value is higher than 56.55% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-10.36
MNPR EV/EBITDA is -10.36

EV/EBITDA Sector rank

10.24%
MNPR EV/EBITDA is higher than 10.24% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

11.47
MNPR annual current ratio is 11.47

Quick ratio

-
MNPR annual quick ratio value is unknown

Leverage

Debt to equity

0.00
MNPR annual debt to equity ratio is 0.00

Interest coverage ratio

-
MNPR annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
MNPR piotroski f-score value is unknown

Altman Z-Score

-
MNPR altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 2, 25 Jones Trading
Hold
Apr 1, 25 HC Wainwright & Co.
Buy
Jan 22, 25 HC Wainwright & Co.
Buy
Jan 10, 25 Piper Sandler
Overweight
Nov 11, 24 HC Wainwright & Co.
Buy
Aug 14, 24 HC Wainwright & Co.
Buy
May 10, 24 HC Wainwright & Co.
Buy
Apr 11, 24 JonesTrading
Buy
Jun 1, 23 HC Wainwright & Co.
Buy
May 15, 23 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

IMMP logo
Immutep Limited (IMMP)
LFCR logo
Lifecore Biomedical (LFCR)
ITOS logo
iTeos Therapeutics (ITOS)
SLDB logo
Solid Biosciences (SLDB)
LUNG logo
Pulmonx (LUNG)
YMAB logo
Y-mAbs Therapeutics (YMAB)
OSUR logo
OraSure Technologies (OSUR)
PDEX logo
Pro-Dex (PDEX)
enGene Holdings (ENGN)
  • What is the ticker symbol for Monopar Therapeutics?
  • Does Monopar Therapeutics pay dividends?
  • What sector is Monopar Therapeutics in?
  • What industry is Monopar Therapeutics in?
  • What country is Monopar Therapeutics based in?
  • When did Monopar Therapeutics go public?
  • Is Monopar Therapeutics in the S&P 500?
  • Is Monopar Therapeutics in the NASDAQ 100?
  • Is Monopar Therapeutics in the Dow Jones?
  • When was Monopar Therapeutics's last earnings report?
  • When does Monopar Therapeutics report earnings?
  • Should I buy Monopar Therapeutics stock now?

What is the ticker symbol for Monopar Therapeutics?

The ticker symbol for Monopar Therapeutics is NASDAQ:MNPR

Does Monopar Therapeutics pay dividends?

No, Monopar Therapeutics does not pay dividends

What sector is Monopar Therapeutics in?

Monopar Therapeutics is in the Healthcare sector

What industry is Monopar Therapeutics in?

Monopar Therapeutics is in the Biotechnology industry

What country is Monopar Therapeutics based in?

Monopar Therapeutics is headquartered in United States

When did Monopar Therapeutics go public?

Monopar Therapeutics's initial public offering (IPO) was on December 19, 2019

Is Monopar Therapeutics in the S&P 500?

No, Monopar Therapeutics is not included in the S&P 500 index

Is Monopar Therapeutics in the NASDAQ 100?

No, Monopar Therapeutics is not included in the NASDAQ 100 index

Is Monopar Therapeutics in the Dow Jones?

No, Monopar Therapeutics is not included in the Dow Jones index

When was Monopar Therapeutics's last earnings report?

Monopar Therapeutics's most recent earnings report was on Mar 31, 2025

When does Monopar Therapeutics report earnings?

The next expected earnings date for Monopar Therapeutics is May 9, 2025

Should I buy Monopar Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page